Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHARIS CHRISTIANA SARRADET

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1841852530
CMS profile
10490067
Location
PLANO, TX

General Payments · PY2021

$254.38

  • Reported across 18 records
  • CMS publication 2026-01-23

Latest program year · PY2021

$254.38

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2021 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $254.38 18

By paying entity

PY2021 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $50.33 4
Amgen Inc. $48.59 3
Acerta Pharma LLC $38.11 3
ABBVIE INC. $26.75 2
ARBOR PHARMACEUTICALS, INC. $26.17 2
GlaxoSmithKline, LLC. $26.05 2
Esperion Therapeutics, Inc. $22.76 1
Amarin Pharma Inc. $15.62 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $254.38 18

Payment records · PY2021 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2021
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AbbVie Inc. $15.38 06/04/2021 Food and Beverage Undisputed 01/23/2026 795421859 CMS
AbbVie Inc. $11.37 07/09/2021 Food and Beverage Undisputed 01/23/2026 795421865 CMS
Amarin Pharma Inc. $15.62 07/30/2021 Food and Beverage Undisputed 01/23/2026 815257917 CMS
Amgen Inc. $13.24 06/07/2021 Food and Beverage Undisputed 01/23/2026 825956475 CMS
Amgen Inc. $17.56 06/17/2021 Food and Beverage Undisputed 01/23/2026 825956467 CMS
Amgen Inc. $17.79 07/22/2021 Food and Beverage Undisputed 01/23/2026 825956471 CMS
ARBOR PHARMACEUTICALS, INC. $12.50 04/26/2021 Food and Beverage Undisputed 01/23/2026 830932245 CMS
ARBOR PHARMACEUTICALS, INC. $13.67 07/01/2021 Food and Beverage Undisputed 01/23/2026 830932275 CMS
AstraZeneca Pharmaceuticals LP $14.62 05/03/2021 Food and Beverage Undisputed 01/23/2026 829625891 CMS
AstraZeneca Pharmaceuticals LP $11.16 07/07/2021 Food and Beverage Undisputed 01/23/2026 830259807 CMS
AstraZeneca Pharmaceuticals LP $12.33 08/20/2021 Food and Beverage Undisputed 01/23/2026 829452111 CMS
Esperion Therapeutics, Inc. $22.76 07/28/2021 Food and Beverage Undisputed 01/23/2026 838505051 CMS
GlaxoSmithKline, LLC. $14.51 05/17/2021 Food and Beverage Undisputed 01/23/2026 802184157 CMS
GlaxoSmithKline, LLC. $11.54 09/07/2021 Food and Beverage Undisputed 01/23/2026 802580217 CMS
Lilly USA, LLC $13.53 04/22/2021 Food and Beverage Undisputed 01/23/2026 818849057 CMS
Lilly USA, LLC $12.06 06/08/2021 Food and Beverage Undisputed 01/23/2026 818774411 CMS
Lilly USA, LLC $12.04 07/26/2021 Food and Beverage Undisputed 01/23/2026 818849059 CMS
Lilly USA, LLC $12.70 08/18/2021 Food and Beverage Undisputed 01/23/2026 818793429 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021
Source files
Dataset page · Bulk file · PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.